Jennyfer: French court to review employee fate amid partial buyout offers
Jennyfer, primarily targeting a teenage audience, has faced financial difficulties for several seasons. The company entered receivership in 2023 and was sold in the summer of 2024 to two of its executives, Yann Pasco and Jean-Charles Gaume, with backing from their Chinese supplier, Shanghai Pure Fashion Garments Co. Ltd. Despite efforts to modernize its image and expand its customer base; the relaunch failed to deliver.
As employees await the court's decision, uncertainty looms. On May 21, stores across the network closed for the day in protest, allowing staff to voice their concerns and push for fair severance arrangements. Signs displayed in store windows read:
'We, the employees, continue to work to the end, with courage, loyalty, and professionalism, despite the uncertainty, moral pressure, and lack of prospects. And today, no recognition. NONE. No bonuses, no compensation, no acknowledgment of our efforts.'
Following the protest, employees reportedly secured a modest gain. Myriam Boumendjel, a representative from the CFE -CGC union, told FashionNetwork.com:
'A value-sharing bonus and a performance bonus tied to work done since the liquidation—about 1,800 euros per employee—were granted. We're working like crazy under difficult conditions, so it's only fair that we receive recognition. The administrators and receivers shouldn't be the only ones benefitting.'
According to reporting by Le Monde, an internal survey by employee representatives revealed that two-thirds of the workforce would prefer to be laid off rather than join a new company under a new owner. A final decision on the bids is not expected this Wednesday but is anticipated in two weeks.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
LeMonde
a day ago
- LeMonde
Rare earths: China's magnet war threatens global industry
The problem took a few weeks to show up on production lines. In early April, China imposed restrictions on the export of certain strategic metals – specifically, heavy rare earths and the magnets made from them. This has created a bottleneck for many industries worldwide that depend on these materials. The automotive sector has already begun to feel the impact. Japanese automaker Suzuki was forced to suspend production of its Swift model on May 26 due to a shortage of certain components – rare earth derivatives, according to the business daily Nikkei. At the end of May, Ford halted production of its Explorer SUV for a week after a supplier ran out of magnets made from rare earth alloys. Meanwhile, one of India's leading manufacturers, Bajaj, stated that if nothing changes, the shortage caused by China would "heavily impact" its production of electric vehicles in July. On Wednesday, June 4, the European automotive industry also revealed its exposure to this risk. Without citing specific cases, the European Association of Automotive Suppliers, Clepa, stated that "these restrictions have led to the closure of several production lines and factories in Europe, and the impact will continue to grow in the coming weeks as stocks are depleted." BMW confirmed that some of its suppliers had been affected. "We have shifted to crisis management," said Sylvain Broux, president of the Comité de liaison des industries fournisseurs de l'automobile (CLIFA) in France, while Jean-Louis Pech, president of the Fédération des industries des équipements pour véhicules, described an "economic war in which Europe also has arguments to put forward."
France 24
2 days ago
- France 24
Trump says fresh US-China trade talks in London next week
The talks in the British capital on Monday will mark the second round of such negotiations between the world's two biggest economies since Trump launched his trade war this year. "The meeting should go very well," said Trump in a post on his Truth Social platform. The president added that US Treasury Secretary Scott Bessent, Commerce Secretary Howard Lutnick and US Trade Representative Jamieson Greer would meet the Chinese team. The first talks between Washington and Beijing since Trump slapped levies on allies and adversaries alike took place in Geneva last month. While Trump had imposed a sweeping 10 percent duty on imports from most trading partners, rates on Chinese goods rocketed as both countries engaged in an escalating tariffs battle. In April, additional US tariffs on many Chinese products hit 145 percent while China hit back with countermeasures of 125 percent. Following the talks last month, both sides agreed to temporarily bring down the levels, with US tariffs cooling to 30 percent and China's levies at 10 percent. But this temporary halt is expected to expire in early August and Trump last week accused China of violating the pact, underscoring deeper differences on both sides. US officials have accused China of slow-walking export approvals of critical minerals and rare earth magnets, a key issue behind Trump's recent remarks. While Trump's long-awaited phone call with Xi this week likely paved the way for further high-level trade talks, a swift resolution to the tariffs impasse remains uncertain. © 2025 AFP
Euronews
2 days ago
- Euronews
EU hits back against 'Buy China' policy in medical devices market
EU member states' representatives voted this week for retaliatory measures against Chinese restrictions on European medical device manufacturers, diplomatic and EU sources confirmed to Euronews. This followed an investigation by the European Commission found "clear evidence" that China unfairly blocked EU-made medical devices from its procurement market. It represents the first countermeasure implemented using an International Procurement Instrument (IPI), which came into force in August 2022, designed to ensure fair access for EU firms to procurement opportunities outside the bloc. Ambassadors adopted the proposal midweek, but the details are expected to be published in the EU's Official Journal in the coming days. 'We had truly hoped that the International Procurement Instrument process would lead to more meaningful dialogue and progress with China, but unfortunately, that hasn't happened yet,' said Oliver Bisazza, CEO of MedTech Europe, the EU's association of medical device manufacturers. Bisazza wants to see the full details before reacting, but he pointed out that medical device companies remain committed to constructive engagement between the EU and China. 'This sector is vital for saving and improving people's lives and maintaining essential healthcare infrastructure, offering crucial services. This is something both parties should consider,' he added. EU companies have long struggled to gain access to China's public procurement market, despite China being one of Europe's largest trading partners for medical devices - accounting for 11% of export destinations in 2022. The Commission's investigation focused on China's government procurement law, which enforces the so-called "Buy China" policy, requiring public entities to prioritise domestic products and services, with limited exceptions. The probe found that EU manufacturers face a range of obstacles, including opaque approval systems, discriminatory certification procedures, vague national interest clauses used to exclude foreign bidders, and pricing pressures that are often unfeasible for European firms. One stark example: in Guangdong Province, the number of 'approved' imported medical devices dropped from 132 in 2019 to just 46 in 2021, highlighting the tightening of market access for EU firms. The China Chamber of Commerce to the EU responded with concern, tweeting that the IPI measures send 'a troubling signal' for bilateral trade ties. In a follow-up statement, the Chamber argued that the targeted use of the IPI risks becoming a de facto trade barrier and urged the EU to reconsider the necessity and long-term impact of such actions. The measures come at a sensitive moment in EU-China relations, which are currently undergoing a tentative diplomatic reset. After years of friction, the two sides have stepped up engagement to manage long-standing disputes. Much of this renewed dialogue is a response to shifting global dynamics, including the Trump-era trade war and broader US-China tensions, which have prompted Brussels to pursue a more balanced approach. A key milestone in this reset is the upcoming EU-China Summit, now confirmed to take place in Beijing in the second half of July 2025. Despite the escalating procurement dispute, a Commission spokesperson downplayed concerns that the IPI measures would damage broader trade relations. 'We've been making very clear to any global partners with whom we believe there is a problem as regards to the level playing field for procurement: should those problems not be removed, we would be forced to take action,' said the spokesperson. On Wednesday, EU Trade Commissioner Maroš Šefčovič met with Chinese Minister Wang Wentao on the sidelines of the OECD Ministerial Council – their third meeting overall and second in person. According to the Commission, the talks covered a wide range of critical bilateral issues as both sides work to ensure progress ahead of the July summit.
